Hospira a Pfizer Company recalls Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.
Recalled August 9, 2017 · FDA recall D-1048-2017 · Hospira a Pfizer
Hazard
Lack of Sterility Assurance · FDA Class II
Units
15,034,600 10 mL multiple dose use vials
Sold at
U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore
Description
Lack of Sterility Assurance
Product
Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25).
Manufacturer(s)
Hospira a Pfizer Company
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →